Biospecifics Tech Cp (BSTC) Stock Price & Overview

NASDAQ:BSTC

Current stock price

88.53
+0.13 (+0.15%)
At close:
88.45
-0.08 (-0.09%)
After Hours:

The current stock price of BSTC is 88.53 null. Today BSTC is up by 0.15%. In the past month the price increased by 0.4%. In the past year, price increased by 59.92%.

BSTC Key Statistics

52-Week Range42 - 89.15
Current BSTC stock price positioned within its 52-week range.
1-Month Range88.16 - 88.57
Current BSTC stock price positioned within its 1-month range.
Market Cap
650.253M
P/E
33.92
Fwd P/E
17.60
EPS (TTM)
2.61
Dividend Yield
N/A

BSTC Stock Performance

Today
+0.15%
1 Week
+0.10%
1 Month
+0.40%
3 Months
+51.05%
Longer-term
6 Months +47.40%
1 Year +59.92%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

BSTC Stock Chart

Biospecifics Tech Cp / BSTC Daily stock chart

BSTC Technical Analysis

ChartMill assigns a technical rating of 9 / 10 to BSTC. When comparing the yearly performance of all stocks, BSTC is one of the better performing stocks in the market, outperforming 90.02% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
BSTC Full Technical Analysis Report

BSTC Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to BSTC. BSTC is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
BSTC Full Fundamental Analysis Report

BSTC Earnings

Next Earnings DateN/A
Last Earnings DateN/A
BSTC Earnings History

BSTC Forecast & Estimates


Analysts
Analysts60
Price TargetN/A
EPS Next Y-57.06%
Revenue Next YearN/A
BSTC Forecast & Estimates

BSTC Financial Highlights

Over the last trailing twelve months BSTC reported a non-GAAP Earnings per Share(EPS) of 2.61. The EPS decreased by -17.41% compared to the year before.


Income Statements
Revenue(TTM)36.59M
Net Income(TTM)17.36M
Industry RankSector Rank
PM (TTM) 47.43%
ROA 12.64%
ROE 12.83%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-14.12%
Sales Q2Q%19.21%
EPS 1Y (TTM)-17.41%
Revenue 1Y (TTM)0.86%
BSTC financials

BSTC Ownership

Ownership
Inst Owners0.02%
Shares7.34M
Float4.86M
Ins Owners24.25%
Short Float %N/A
Short RatioN/A
BSTC Ownership

About BSTC

Company Profile

BIOSPECIFICS TECHNOLOGIES is engaged in the business of producing and licensing, for sale by other, a U.S. Food and Drug Administration (``FDA``) approved enzyme derived from collagenase, named Collagenase ABC, and researching, developing and clinically testing additional products derived therefrom for potential use as pharmaceuticals.

Company Info

Biospecifics Tech Cp

2 Righter Parkway Suite 200

Wilmington DE 19803

CEO: J. Kevin Buchi

Phone: 302-842-8450

Biospecifics Tech Cp / BSTC FAQ

What does Biospecifics Tech Cp do?

BIOSPECIFICS TECHNOLOGIES is engaged in the business of producing and licensing, for sale by other, a U.S. Food and Drug Administration (``FDA``) approved enzyme derived from collagenase, named Collagenase ABC, and researching, developing and clinically testing additional products derived therefrom for potential use as pharmaceuticals.


What is the current price of BSTC stock?

The current stock price of BSTC is 88.53 null. The price increased by 0.15% in the last trading session.


What is the dividend status of Biospecifics Tech Cp?

BSTC does not pay a dividend.


How is the ChartMill rating for Biospecifics Tech Cp?

BSTC has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Where is Biospecifics Tech Cp (BSTC) stock traded?

BSTC stock is listed on the Nasdaq exchange.


Should I buy BSTC stock?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on BSTC.


What is the ownership structure of Biospecifics Tech Cp (BSTC)?

You can find the ownership structure of Biospecifics Tech Cp (BSTC) on the Ownership tab.